Strategic proposals to avoid drug interactions during drug development: A lesson from a terfenadine-related drug interaction

Journal of Toxicological Sciences

Volumn 21, Issue 5, 1996, Pages 301-303

  Ishizaki, Takashi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE; TERFENADINE;

CONFERENCE PAPER; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG INTOXICATION; HUMAN; TORSADE DES POINTES;

EID: 0030483169     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.21.5_301     Document Type: Conference Paper

References (15)

1. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996; 275: 1339-1341.
2. Davies AJ, Harindra V, McEwan A, Chose RR. Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 1989; 298: 325.
3. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986; 292: 660.
4. Hoppu K, Tikanoja T, Tapanainen P, Remes M, Saarenpaa-Heikkila O, Kouvalainen K. Accidental astemizole overdose in young children. Lancet 1991 ; 338: 538-540.
5. Wiley JF, Gelber ML, Henretig FM, Wiley CC, Sandhu S, Loiselle J. Cardiotoxic effects of astemizole overdose in children. J Pediatr 1992; 120: 799-802.
6. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 1996; 36: 233-252.
7. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr. Torsades de pointes occurring in association with terfenadine use. JAMA 1990; 264: 2788-2790.
8. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR Jr. Terfenadine-ketoconazole interaction: Pharmacokinetic and electrocardiographic consequences. JAMA 1993; 269: 1513-1518.
9. Woosley RL, Chen Y, Freiman JP, Gillis RA, Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 1532-1536.
10. Peck CC, Temple R, Collins JM. Understanding consequences of concurrent therapies. JAMA 1993; 269: 1550-1552.
11. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992; 52: 231-238.
12. Yun CH, Okerholm RA, Guengerich FP. Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cytochrome P450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 1993; 21: 403-409.
13. Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin. Br Med J 1978; 1: 279-280.
14. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Critical Rev Toxicol 1992; 22: 1-21
15. Brockmdller J, Roots I. Assessment of liver metabolic function: Clinical imlications. Clin Pharmacokinet 1994; 27: 216-248.